Geode Capital Management, LLC Geo Vax Labs, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.51 - $0.62 $73 - $89	145 Added 0.08%	172,895 $88,000
Q4 2022 Feb 13, 2023	BUY	$0.55 - $17.1 $14,554 - $452,500	26,462 Added 18.09%	172,750 $108,000
Q3 2022 Nov 14, 2022	BUY	$0.4 - $58.5 $36,578 - $5.35 Million	91,446 Added 166.74%	146,288 $159,000
Q2 2022 Aug 12, 2022	BUY	$9.29 - $34.8 $18,747 - $70,226	2,018 Added 3.82%	54,842 $45,000
Q4 2021 Feb 11, 2022	SELL	$52.65 - $71.7 $330,273 - $449,774	-6,273 Reduced 10.61%	52,824 $191,000
Q3 2021 Nov 12, 2021	BUY	$56.4 - $91.35 $380,079 - $615,607	6,739 Added 12.87%	59,097 $255,000
Q2 2021 Aug 13, 2021	BUY	$64.8 - $94.5 $961,696 - $1.4 Million	14,841 Added 39.56%	52,358 $261,000
Q1 2021 May 12, 2021	BUY	$49.05 - $126.6 $1.84 Million - $4.75 Million	37,517 New	37,517 $164,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $51.2M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.